Allogene Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $3.6M | 1.5M | 2.33 |
| 2024-03-31 | $5.8M | 1.3M | 4.47 |
| 2023-12-31 | $11M | 3.3M | 3.21 |
| 2023-09-30 | $4.5M | 1.4M | 3.17 |
| 2023-06-30 | $7.5M | 1.5M | 4.97 |
| 2023-03-31 | $5.7M | 1.2M | 4.94 |
| 2022-12-31 | $10M | 1.6M | 6.29 |
| 2022-06-30 | $23M | 2.0M | 11.40 |
| 2022-03-31 | $27M | 3.0M | 9.11 |
| 2021-12-31 | $27M | 1.8M | 14.92 |
| 2021-09-30 | $51M | 2.0M | 25.70 |
| 2021-03-31 | $45M | 1.3M | 35.30 |
| 2020-12-31 | $35M | 1.4M | 25.24 |
| 2020-09-30 | $35M | 927k | 37.71 |
| 2020-06-30 | $15M | 346k | 42.81 |
| 2019-12-31 | $4.5M | 175k | 25.98 |
| 2019-09-30 | $2.9M | 105k | 27.25 |
| 2019-06-30 | $2.1M | 79k | 26.85 |
| 2019-03-31 | $1.8M | 63k | 28.90 |
| 2018-12-31 | $1.6M | 61k | 26.92 |